green
Positive treatment
2.2 score
Treatment trajectory · 1997 → 2026 · click a year to view as-of
1997
2011
2026
Top citers, strongest first. 4 distinct citers.
How cited ↗
discussed
Cited "see"
Brawn v. Coleman
See Martin v. Shaw’s Supermarkets, Inc., 105 F.3d 40, 42 (1st Cir.) (holding that § 301 preemption applies only to “a real interpretive dispute and not merely a pretended dispute.”), cer t. denied, 522 U.S. 818 , 118 S.Ct. 69 , 139 L.Ed.2d 30 (1997).
cited
Cited "see"
Flibotte v. PA Truck Lines, Inc.
See Martin v. Shaw's Supermarkets, Inc., 105 F.3d 40, 41-42 (1st Cir.) (recounting development of section 301 preemption), cert. denied, 118 S. Ct. 69 (1997).
cited
Cited "see"
Albert A. Flibotte v. Pennsylvania Truck Lines, Inc.
See Martin v. Shaw’s Supermarkets, Inc., 105 F.3d 40, 41-42 (1st Cir.) (recounting development of section 301 preemption), cert. denied, — U.S. -, 118 S.Ct. 69 , 139 L.Ed.2d 30 (1997).
discussed
Cited "see, e.g."
Pharmacia & Upjohn Co. v. Mylan Pharmaceuticals, Inc.
See also Wang Lab. v. Mitsubishi Electronics America, Inc., 103 F.3d 1571 (Fed.Cir.l997), cert, denied, — U.S. -, 118 S.Ct. 69 , 139 L.Ed.2d 30 (1997) (prosecution history estoppel precluded finding of infringement); Mark I Mktg.
Retrieving the full opinion text from the archive…
Wang Laboratories, Inc.
v.
Mitsubishi Electronics America, Inc.
v.
Mitsubishi Electronics America, Inc.
No. 96-1960.
Supreme Court of the United States.
Oct 6, 1997.
Published
C. A. Fed. Cir. Certiorari denied.